Company news

Processa Pharmaceuticals, Inc. news in 2026

Processa Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya Therapeutics

October 29, 2026

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

September 1, 2026

Processa Pharmaceuticals, Inc. announces acquisition of Vidya Therapeutics, Inc. and approximately $200 million concurrent private placement to advance BTK inhibitor, VT-7208, in multiple disease areas

July 29, 2026

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

January 5, 2026

Decks in 2026